 UBBFriend: Email This Page to Someone! |
 HUM-MOLGEN
 DIAGnostics - Clinical Research (professional requests)
 STTR - models to predict hemolytic toxicity of drugs in G6PD-deficiency
|
| next newest topic | next oldest topic |
| Author | Topic: STTR - models to predict hemolytic toxicity of drugs in G6PD-deficiency |
|
Administrator Administrator |
posted 02-27-2006 07:59 PM
  
Dear Colleagues, I am a physician at Walter Reed. We are seeking STTR (Small Business Technology Transfer) applicants to develop and validate models to predict hemolytic toxicity of drugs in G6PD-deficiency. This toxicity is a common problem with new antimalarial drugs. A predictive model would greatly facilitate our ability to develop new safe antimalarials for our military, and for civilians suffering from this disease world-wide. Each year, there are 1-3 million deaths and 500,000,000 clinical cases from malaria. Please see information at the links below. If this is not a good fit for your company, please forward the information to other companies or universities that may be interested. Sincerely, Colin Ohrt, MD, MPH IP: 194.97.163.115 |
All times are ET (US) | next newest topic | next oldest topic |
  |
|
Contact Us | HUM-MOLGEN
Copyright by HUM-MOLGEN 1995-2017
Powered by: Ultimate Bulletin Board, Version 5.44a
© Infopop Corporation (formerly Madrona Park, Inc.), 1998 - 2000.